Shanghai General Healthy Information and Technology Co. Ltd. (605186) - Total Assets
Based on the latest financial reports, Shanghai General Healthy Information and Technology Co. Ltd. (605186) holds total assets worth CN¥1.59 Billion CNY (≈ $232.02 Million USD) as of September 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Explore Shanghai General Healthy Information and (605186) cash flow to debt to assess how comfortably operating cash covers total debt obligations.
Shanghai General Healthy Information and Technology Co. Ltd. - Total Assets Trend (2016–2024)
This chart illustrates how Shanghai General Healthy Information and Technology Co. Ltd.'s total assets have evolved over time, based on quarterly financial data. See Shanghai General Healthy Information and (605186) net assets for net asset value and shareholders' equity analysis.
Shanghai General Healthy Information and Technology Co. Ltd. - Asset Composition Analysis
Current Asset Composition (December 2024)
Shanghai General Healthy Information and Technology Co. Ltd.'s total assets of CN¥1.59 Billion consist of 51.0% current assets and 49.0% non-current assets.
| Asset Category | Amount (CNY) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 8.5% |
| Accounts Receivable | CN¥488.12 Million | 33.3% |
| Inventory | CN¥99.69 Million | 6.8% |
| Property, Plant & Equipment | CN¥0.00 | 0.0% |
| Intangible Assets | CN¥38.26 Million | 2.6% |
| Goodwill | CN¥0.00 | 0.0% |
Asset Composition Trend (2016–2024)
This chart illustrates how Shanghai General Healthy Information and Technology Co. Ltd.'s asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see market value of Shanghai General Healthy Information and.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Shanghai General Healthy Information and Technology Co. Ltd.'s current assets represent 51.0% of total assets in 2024, a decrease from 87.7% in 2016.
- Cash Position: Cash and equivalents constituted 8.5% of total assets in 2024, down from 36.7% in 2016.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 2.0% of total assets, an increase from 0.0% in 2016.
- Asset Diversification: The largest asset category is accounts receivable at 33.3% of total assets.
Shanghai General Healthy Information and Technology Co. Ltd. Competitors by Total Assets
Key competitors of Shanghai General Healthy Information and Technology Co. Ltd. based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Shenzhen New Industries Biomedical
SHE:300832
|
China | CN¥9.58 Billion |
|
COCHLEAR LTD ADR 1/2/O.N.
F:OC50
|
Germany | €2.83 Billion |
|
Double Medical Technology Inc
SHE:002901
|
China | CN¥5.03 Billion |
|
Shanghai MicroPort EV MedTech Co. Ltd. A
SHG:688351
|
China | CN¥2.00 Billion |
|
Sinocare Inc
SHE:300298
|
China | CN¥6.25 Billion |
|
Vitrolife AB
ST:VITR
|
Sweden | Skr11.24 Billion |
|
HOB Biotech Group Corp Ltd
SHG:688656
|
China | CN¥912.83 Million |
|
Imricor Medical Systems Inc
AU:IMR
|
Australia | AU$45.79 Million |
Shanghai General Healthy Information and Technology Co. Ltd. - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 2.06 | 2.87 | 7.02 |
| Quick Ratio | 1.82 | 2.58 | 6.81 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | CN¥443.51 Million | CN¥533.19 Million | CN¥705.03 Million |
Shanghai General Healthy Information and Technology Co. Ltd. - Advanced Valuation Insights
This section examines the relationship between Shanghai General Healthy Information and Technology Co. Ltd.'s asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 2.83 |
| Latest Market Cap to Assets Ratio | 0.34 |
| Asset Growth Rate (YoY) | 11.3% |
| Total Assets | CN¥1.47 Billion |
| Market Capitalization | $495.34 Million USD |
Valuation Analysis
Below Book Valuation: The market values Shanghai General Healthy Information and Technology Co. Ltd.'s assets below their book value (0.34x), which may indicate investor concerns about asset quality or future growth.
Rapid Asset Growth: Shanghai General Healthy Information and Technology Co. Ltd.'s assets grew by 11.3% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for Shanghai General Healthy Information and Technology Co. Ltd. (2016–2024)
The table below shows the annual total assets of Shanghai General Healthy Information and Technology Co. Ltd. from 2016 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | CN¥1.47 Billion ≈ $214.52 Million |
+11.33% |
| 2023-12-31 | CN¥1.32 Billion ≈ $192.69 Million |
+9.84% |
| 2022-12-31 | CN¥1.20 Billion ≈ $175.43 Million |
+6.13% |
| 2021-12-31 | CN¥1.13 Billion ≈ $165.29 Million |
+13.25% |
| 2020-12-31 | CN¥997.40 Million ≈ $145.95 Million |
+106.76% |
| 2019-12-31 | CN¥482.40 Million ≈ $70.59 Million |
+35.74% |
| 2018-12-31 | CN¥355.39 Million ≈ $52.00 Million |
+34.90% |
| 2017-12-31 | CN¥263.46 Million ≈ $38.55 Million |
+2.65% |
| 2016-12-31 | CN¥256.67 Million ≈ $37.56 Million |
-- |
About Shanghai General Healthy Information and Technology Co. Ltd.
Shanghai General Healthy Information and Technology Co., Ltd. provides pharmaceutical logistics automation, information technology, and intelligent and mobile medical solutions in China. The company's products include the Smart Pharmacy Project, an intelligent drug management system that combines software and hardware; intelligent static distribution center project, an intelligent intravenous dru… Read more